Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis

Marta Pengo1, Silvia Miante1, Silvia Franciotta1

  • 1From the Multiple Sclerosis Centre (M. Pengo, S.M., S.F., M.S., M.M., P.G., M. Puthenparampil), Neurology Clinic, Department of Neuroscience, Università degli Studi di Padova; Department of Health Sciences (M. Ponzano, F.B., M.P.S.), Section of Biostatistics, University of Genova; Ophthalmology Clinic (T.T., E.P., E.M.), Department of Neuroscience, Università degli Studi di Padova, Italy; Fellow of the European Board of Ophthalmology (T.T., E.P., E.M.), London, United Kingdom; Multiple Sclerosis Centre (F.R., P.P.), Neurology Clinic, Azienda Ospedaliera di Padova; and Department of Information Engineering (DEI) (A.B.), University of Padova, Italy.

Abstract

Insights

Retinal microglia clusters (hyperreflecting foci or HRF) are elevated in early multiple sclerosis (MS) patients. Higher HRF counts correlate with disease activity, suggesting HRF as a potential prognostic biomarker for MS.

Area of Science:

  • Neuroimmunology
  • Ophthalmology
  • Radiology

Background:

  • Microglia, the brain's immune cells, are activated in multiple sclerosis (MS).
  • Retinal microglia activation, visualized as hyperreflecting foci (HRF), is widespread in MS.
  • The association between HRF and clinical/radiological parameters in early relapsing-remitting MS (RRMS) requires evaluation.

Purpose of the Study:

  • To assess the presence and number of retinal HRF in patients with early RRMS.
  • To investigate the correlation between HRF and clinical/radiological disease parameters.
  • To explore HRF as a potential prognostic biomarker in RRMS.

Main Methods:

  • 80 RRMS patients underwent optical coherence tomography (OCT) and 3T-MRI near disease onset.
  • Patients were followed for 43 months, assessing no evidence of disease activity (NEDA) status.
  • Exclusion criteria included a history of optic neuritis (ON) or suggestive MRI/OCT findings.

Main Results:

  • HRF counts were significantly higher in the inner nuclear layer (INL) of RRMS patients compared to controls.
  • HRF count correlated with INL volume and gray matter (GM) lesion volume.
  • Higher INL HRF counts were associated with both clinical (cNEDA) and radiological (rNEDA) disease activity.

Conclusions:

  • A strong association exists between retinal microglial proliferation (HRF) and cortical pathology in RRMS.
  • Microglial activation at baseline, indicated by HRF, may predict future inflammatory events.
  • HRF shows promise as a prognostic biomarker for MS, warranting further investigation.